Abiopharma

Director AKKARAJU SRINIVAS 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000008

Wong Rich 🟢 acquired 19.2K shares of UiPath, Inc. (PATH) Transaction Date: Jun 25, 2026 | Filing ID: 000002

📋 Harold Shlevin (Director) plans to sell 22K shares of GALECTIN THERAPEUTICS INCORPORATED (at $5.04 each, total $112K) Filed: Jun 29, 2026 | ID: 045997

Director Weiss Shai 🟢 acquired 4.2K shares of Navan, Inc. (NAVN) Transaction Date: Jun 25, 2026 | Filing ID: 045996

Brownlie Keith L 🟢 acquired 26.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 Transaction Date: Jun 25, 2026 | Filing ID: 000002

Springer Daniel D. 🟢 acquired 19.2K shares of UiPath, Inc. (PATH) Transaction Date: Jun 25, 2026 | Filing ID: 000003

Director Al-Marzooqi Fahed 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000003

Mo Luyi 🟡 adjusted position in 14.5K shares (5 derivative) of Pony AI Inc. (PONY) at $6.86 Transaction Date: Jun 25, 2026 | Filing ID: 078826

Director Williams Anre D 🟢 acquired 10.0K shares of Navan, Inc. (NAVN) Transaction Date: Jun 25, 2026 | Filing ID: 045994

Director Phillips Anne M. 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000006